[Prix Galien Korea 2026] KDDF CEO Park Yeong-min Appointed Chair of 'the Prix Galien Korea' Judging Committee(9/10, The Shilla Seoul)
- 2026.09.08
- 99
Park Yeong-min, CEO of the Korea Drug Development Fund (KDDF), has been appointed Chair of the Judging Committee for the inaugural Prix Galien Korea, widely regarded as the world’s most prestigious awards program in the pharmaceutical and biotechnology industry and often referred to as the “Nobel Prize of biopharmaceutical innovation.”
KDDF expects the introduction of the Prix Galien Korea in Korea, along with Park’s participation as Chair of the Judging Committee,
to provide a strong impetus to Korea’s drug development ecosystem and serve as a milestone for the future direction of K-Bio.
The official ceremony, where the final winners across five categories will be announced, will be held on September 10 (Thursday).
We warmly invite researchers and industry professionals in the field of drug development to take an interest in and support this prestigious event.
Visit the Official Prix Galien Korea Website: https://www.mk.co.kr/prixgalienkorea
